| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A rare case of anal carcinosarcoma with human papilloma virus infection in both biphasic tumor elements: An immunohistochemical, molecular and ultrastructural study
|
Hickman, Richard A.
|
|
|
2 |
C |
p. 164-166
|
article
|
| 2 |
Challenges in educating women about human papillomavirus (HPV) and HPV screening test results: Experience from an HPV demonstration project in North-Eastern Thailand
|
Senkomago, Virginia
|
|
|
2 |
C |
p. 190-192
|
article
|
| 3 |
Clinical and analytical performance of the BD Onclarity™ HPV assay for detection of CIN2+ lesions on SurePath samples
|
Ejegod, Ditte Møller
|
|
|
2 |
C |
p. 31-37
|
article
|
| 4 |
Development of World Health Organization (WHO) recommendations for appropriate clinical trial endpoints for next-generation Human Papillomavirus (HPV) vaccines
|
Prabhu, Malavika
|
|
|
2 |
C |
p. 185-189
|
article
|
| 5 |
Ethnic background and human papillomavirus vaccine uptake in Denmark: A countrywide retrospective cohort study including 274,154 women aged 19–28 years
|
Fernández de Casadevante, Victoria
|
|
|
2 |
C |
p. 78-84
|
article
|
| 6 |
Examining maternal beliefs and human papillomavirus vaccine uptake among male and female children in low-income families
|
Fuchs, Erika L.
|
|
|
2 |
C |
p. 38-40
|
article
|
| 7 |
Factors affecting HPV vaccine acceptance in west Austria: Do we need to revise the current immunization scheme?
|
Borena, Wegene
|
|
|
2 |
C |
p. 173-177
|
article
|
| 8 |
Healthcare providers’ beliefs and attitudes regarding risk compensation following HPV vaccination
|
Kasting, Monica L.
|
|
|
2 |
C |
p. 116-121
|
article
|
| 9 |
High specific immune response to a bivalent anti-HPV vaccine in HIV-1-infected men in São Paulo, Brazil
|
Fontes, Adriele
|
|
|
2 |
C |
p. 17-20
|
article
|
| 10 |
HPV distribution in cervical cancer in Portugal. A retrospective study from 1928 to 2005
|
Félix, Ana
|
|
|
2 |
C |
p. 41-45
|
article
|
| 11 |
HPV16 E6 seropositivity among cancer-free men with oral, anal or genital HPV16 infection
|
Beachler, Daniel C.
|
|
|
2 |
C |
p. 141-144
|
article
|
| 12 |
HPV vaccination initiation after the routine-recommended ages of 11–12 in the United States
|
Beachler, Daniel C.
|
|
|
2 |
C |
p. 11-16
|
article
|
| 13 |
HPV vaccination intention among male clients of a large STI outpatient clinic in Amsterdam, the Netherlands
|
Marra, E.
|
|
|
2 |
C |
p. 178-184
|
article
|
| 14 |
HPV vaccine completion and dose adherence among commercially insured females aged 9 through 26 years in the US
|
Liu, Guodong
|
|
|
2 |
C |
p. 1-8
|
article
|
| 15 |
Human papillomavirus detection in cervical neoplasia attributed to 12 high-risk human papillomavirus genotypes by region
|
Castellsagué, Xavier
|
|
|
2 |
C |
p. 61-69
|
article
|
| 16 |
Human papillomavirus (HPV) perinatal transmission and risk of HPV persistence among children: Design, methods and preliminary results of the HERITAGE study
|
Trottier, Helen
|
|
|
2 |
C |
p. 145-152
|
article
|
| 17 |
Human papillomavirus prevalence and type distribution in urine samples from Norwegian women aged 17 and 21 years: A nationwide cross-sectional study of three non-vaccinated birth cohorts
|
Molden, Tor
|
|
|
2 |
C |
p. 153-158
|
article
|
| 18 |
IPVS Policy statement on safety of HPV vaccines
|
.,
|
|
|
2 |
C |
p. 9-10
|
article
|
| 19 |
Knowledge, attitudes, and perception towards human papillomavirus among university students in Pakistan
|
Khan, Tahir Mehmood
|
|
|
2 |
C |
p. 122-127
|
article
|
| 20 |
Low prevalence of HPV-driven head and neck squamous cell carcinoma in North-East Italy
|
Baboci, Lorena
|
|
|
2 |
C |
p. 133-140
|
article
|
| 21 |
Molecular events leading to HPV-induced high grade neoplasia
|
Wilting, Saskia M.
|
|
|
2 |
C |
p. 85-88
|
article
|
| 22 |
Monitoring the impact of HPV vaccine in males—Considerations and challenges
|
Brotherton, Julia M.L.
|
|
|
2 |
C |
p. 106-111
|
article
|
| 23 |
Need for expanded HPV genotyping for cervical screening
|
Cuzick, Jack
|
|
|
2 |
C |
p. 112-115
|
article
|
| 24 |
Novel canine papillomavirus type 18 found in pigmented plaques
|
Lange, Christian E.
|
|
|
2 |
C |
p. 159-163
|
article
|
| 25 |
p16(INK4A) expression in invasive laryngeal cancer
|
Hernandez, Brenda Y.
|
|
|
2 |
C |
p. 52-55
|
article
|
| 26 |
Prevalence and risk factors associated with high-grade anal squamous intraepithelial lesions (HSIL)-AIN2 and HSIL-AIN3 in homosexual men
|
Machalek, Dorothy A.
|
|
|
2 |
C |
p. 97-105
|
article
|
| 27 |
Prevalence, genotyping, and correlates of anogenital HPV infection in a population-based sample of women in Puerto Rico
|
Ortiz, A.P.
|
|
|
2 |
C |
p. 89-96
|
article
|
| 28 |
Statewide analysis of missed opportunities for human papillomavirus vaccination using vaccine registry data
|
Kepka, Deanna
|
|
|
2 |
C |
p. 128-132
|
article
|
| 29 |
T cell ignorance is bliss: T cells are not tolerized by Langerhans cells presenting human papillomavirus antigens in the absence of costimulation
|
Woodham, Andrew W.
|
|
|
2 |
C |
p. 21-30
|
article
|
| 30 |
The high-risk HPV E6 target scribble (hScrib) is required for HPV E6 expression in cervical tumour-derived cell lines
|
Kranjec, Christian
|
|
|
2 |
C |
p. 70-77
|
article
|
| 31 |
Validation of the vaccine conspiracy beliefs scale
|
Shapiro, Gilla K.
|
|
|
2 |
C |
p. 167-172
|
article
|
| 32 |
What explains the different rates of human papillomavirus vaccination among adolescent males and females in the United States?
|
Choi, Yoonyoung
|
|
|
2 |
C |
p. 46-51
|
article
|
| 33 |
Xpert human papillomavirus test is a promising cervical cancer screening test for HIV-seropositive women
|
Mbulawa, Zizipho Z.A.
|
|
|
2 |
C |
p. 56-60
|
article
|
Journal description